Evidence map›Paper›PMID 34951123›Full record

ArticleCNS neuroscience & therapeutics2022

CELSR3 variants are associated with febrile seizures and epilepsy with antecedent febrile seizures.

Jia Li, Si-Mei Lin, Jing-Da Qiao, Xiao-Rong Liu, Jie Wang, Mi Jiang, Jing Zhang, Min Zhong, Xu-Qin Chen, Jing Zhu and 6 more

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Genes & diseases · 2025
    Article
  6. Review
  7. Article
  8. Variants inJournal of medical genetics · 2023
    Article
  9. Frontiers in molecular neuroscience · 2023
    Article
  10. Frontiers in molecular neuroscience · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jia LiInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Si-Mei LinInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Jing-Da QiaoInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.ORCID 0000-0002-4693-8390
Xiao-Rong LiuInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Jie WangInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Mi JiangInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Jing ZhangDepartment of Pediatrics, Xiangya Changde Hospital, Changde, China.
Min ZhongDepartment of Neurology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Xu-Qin ChenDepartment of Neurology, Children's Hospital of Soochow University, Suzhou, China.
Jing ZhuDepartment of Pediatrics, The First Hospital of Anhui Medical University, Hefei, China.
Na HeInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Tao SuInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Yi-Wu ShiInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Yong-Hong YiInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.
Wei-Ping LiaoInstitute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.ORCID 0000-0001-9929-9185
China Epilepsy Gene 1.0 Project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo identify novel pathogenic gene of febrile seizures (FS)/epilepsy with antecedent FS (EFS+).

methodsThe trio-based whole-exome sequencing was performed in a cohort of 462 cases with FS/EFS+. Silico programs, sequence alignment, and protein modeling were used to predict the damaging of variants. Statistical testing was performed to analyze gene-based burden of variants.

resultsFive heterozygous missense variants in CELSR3 were detected in five cases (families) with eight individuals (five females, three males) affected. Two variants were de novo, and three were identified in families with more than one individual affected. All the variants were predicted to be damaging in silico tools. Protein modeling showed that the variants resulted in disappearance of multiple hydrogen bonds and one disulfide bond, which potentially caused functional impairments of protein. The frequency of CELSR3 variants identified in this study was significantly higher than that in controls. All affected individuals were diagnosed with FS/EFS+, including six patients with FS and two patients with EFS+. All cases presented favorable outcomes without neurodevelopmental disorders.

conclusionsCELSR3 variants are potentially associated with FS/EFS+.

Indexed as

CadherinsEpilepsyReceptors, Cell SurfaceSeizures, FebrileExome SequencingFemaleHumansMaleMutationMutation, MissenseCadherinsCelsr3 protein, humanReceptors, Cell SurfaceCELSR3epilepsyfebrile seizurespathogenic genetrio-based whole-exome sequencing

Identifiers

PMID34951123
PMCPMC8841303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.